Background: Autophagy-related genes ATG4B, ATG7, and ATG12 have been identified to play a critical role in viral replication. However, these genes have yet to be identified in hepatitis B virus (HBV).
Introduction
Hepatitis B virus (HBV) infection is a serious and life-threatening health problem. Approximately 350 million people worldwide are chronically infected with HBV. If left untreated, this deadly virus leads to chronic diseases including liver cirrhosis and hepatocellular carcinoma (HCC) which claims the lives of approximately 1 million people each year. 1 Autophagy is a catabolic pathway for recycling nutrients to maintain cellular homeostasis. It has also been implicated in innate and adaptive immunity to eliminate intracellular pathogens. 2 However, recent studies have demonstrated that some viruses defeat the autophagic pathway for their own benefit. A recent report showed that HBV induces autophagic process for its replication without increasing autophagic protein degradation. [3] [4] [5] Numerous studies have been conducted to identify molecular pathways that regulate autophagy. A class III phosphatidylinositol 3-kinase (PIK3C3) has been reported as an important regulator in the autophagic process. PIK3C3 consists of a catalytic subunit hVps34 and a regulatory subunit p150. It has been shown to complex with Beclin-1/ATG6, UVRAG, and Bif-1, which is necessary for the initiation of autophagy. 6 A recent study showed that HBV induces autophagy for its DNA replication through the X protein (HBx) which binds to PIK3C3. 3 Moreover, a function of HBx in increasing autophagy through the up-regulation of beclin 1 expression was observed in the study of Tang et al. 7 In addition to the regulators of initiation of autophagy, the conjugation systems for the formation of autophagosomes are also crucial. There are two ubiquitin-like conjugation systems. The first is the coupling of autophagy-related genes (ATG) 12 to ATG5 to form a covalently linked heterodimer, which then recruits ATG16 to form ATG12-ATG5-ATG16 complex. The second system is the ATG8/LC3 conjugated to the phospholipid phosphatidylethanolamine. Several kinds of enzymes composed of ATG4B, ATG7, and ATG3 are required for lipidation of LC3, which is important for the formation of autophagosomes. 8, 9 Some genes and/or proteins in the ubiquitin-like conjugation systems have been reported to play a role in hepatitis C virus (HCV) infection such as ATG12, ATG4B, and ATG7. 10, 11 To clarify these autophagy-related genes in HBV disease, the ATG4B, ATG7, and ATG12 were characterised under starvation conditions.
Methods

Cell lines
The human hepatoma cell line (HepG2) and the HBV-transfected HepG2.2.15 cell line were kindly provided from Professor Antonio Bertoletti (Singapore Institute for Clinical Sciences (A*Star). Both cell lines were cultured in Dulbecco's modified Eagles' medium supplemented with 10% foetal bovine serum and antibiotics (penicillin 100 IU/ml, streptomycin 100 μg/ml) (Invitrogen). In addition, the HepG2.2.15 cells were supplemented with 150 µg/ml Geneticin® (G418 Sulphate; Gibco) for maintaining HBV plasmid. For autophagy induction, HepG2 and HepG2.2.15 cells were incubated in starvation medium (Earle's Balanced Salt Solution: EBSS; Gibco) at 37ºC in 5% CO 2 for 4 and 8 h. All cells were collected by trypsinisation with 0.25% trypsin/EDTA (Gibco) and washed with phosphate-buffered saline (PBS). The cell pellet was re-suspended in RNAlater® Solution (Ambion) and stored at -20ºC until used. Table 1 ). The PCR amplification was performed on the Applied Biosystems 7500 Real-Time PCR System using thermal cycling conditions: 10 min at 95ºC, followed by 40 cycles of 15 sec at 95ºC, 1 min at 60ºC. The derivation of the 2 -ddCT method was applied for relative quantification of mRNA expression. 
Western blot analysis
Non-starved and starved HepG2 and HepG2.2.15 cells were collected and lysed with RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS). After sonication, the protein concentration of cell lysates was measured using the BCA assay (Pierce™). A total of 20 µg of proteins from each cell line was loaded onto 12% polyacrylamide gel and run at 130 V for 75 min. The proteins were transferred onto nitrocellulose membrane and were immunoblotted with the primary monoclonal antibodies (mAb) against Atg7, Atg12, Beta actin (dilution, 1:1000; Rabbit mAb; Cell Signaling Technologies) and Atg4B (dilution, 1:1000; Mouse mAb; Abcam). After washing, the membranes were incubated with secondary antibodies conjugated with horseradish peroxidase (dilution 1:2000) and were then analysed with enhanced chemiluminescence (ECL) substrate (SuperSignal West Femto Chemiluminescent Substrate; Pierce TM ). Image was quantified using Licor-odyssey image system (LI-COR®).
RNA interference
HepG2.2.15 cells were transiently transfected with 500 ng of short hairpin RNA (shRNA) plasmid specific to ATG12 and negative control (SureSilencing shRNA Plasmid; QIAGEN). The shATG12 plasmid contained following sequences: 5'-CGAACCATCCAAGGACTCATT-3'. Negative control inserted with a mock target sequence as follows: 5'-GGAATCTCATTCGATGCATAC-3'. Transfection of shRNA plasmids were carried out using Lipofectamine ® 2000 (Invitrogen) according to the manufacturer's instructions. At 72 h posttransfection, cells were collected and the silencing efficiency of the shRNA was detected by Western blotting.
Quantification of intracellular HBV replication
Total DNA from silencing ATG12-HepG2.2.15 cells and mock-treatment HepG2.2.15 cells were isolated using the QIAamp DNA Blood Mini Kit (Qiagen). For viral DNA quantification, a standard copy number of HBV was used. Specific primers for PreS1 HBV gene were newly designed, as shown in Table 1 . The PCR amplification was performed with SYBR green on the Applied Biosystems 7500 RealTime PCR System.
Apoptosis assay
Apoptotic cells were detected by using APClabelled Annexin V binding (Invitrogen, CA, USA) and Fixable Viability Dye eFluor® 780 staining (eBioscience). Total apoptotic cells are early apoptotic cells defined as annexin V-positive and Fixable Viability Dye eFluor® 780-negative combined with late apoptotic cells defined as both annexin V-positive and Fixable Viability Dye eFluor® 780-positive. Cells were acquired on a FACScan (BD Biosciences) and analysed with FlowJo 10.0 software (FlowJo LLC., USA).
Statistical analysis
Significant differences were determined by unpaired t test with GraphPad Prism, version 5.0 software (San Diego, California, USA). The statistical significance was set at P-value of p <0.05 (*), p <0.005 (**) and p <0.0001 (***).
Result
ATG12 is up-regulated in HBV-transfected cells under starvation condition.
More than 30 autophagy-related genes are involved in autophagic processes.
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Beclin1 is an essential autophagy regulator binding to PIK3C3 (Vps34) which is a critical enzyme for the initiation of autophagy.
14 Previous studies have shown that autophagy induction is mediated by the HBx protein, which binds to PIK3C3 for viral replication. 3 Moreover, the viral regulatory protein HBx was involved in starvation-induced autophagy via the up-regulation of Beclin1 expression. 7 Therefore, we chose Beclin1 and PIK3C3 as a marker for HBV-induced autophagy in starvation condition. We analysed the Beclin1 and PIK3C3 mRNA expression in HBV-transfected HepG2.2.15 and HepG2 cells. At 4 h post-starvation, Beclin1 and PIK3C3 were up-regulated in both of cell lines and were then down-regulated at 8 h (data not shown). Afterwards, we selected the optimal condition of autophagy induction for both cell lines with starvation in EBSS for 4 h. The candidate of autophagy related genes including ATG4B, ATG7, and ATG12 were determined the mRNA expression level at 4 h post-culture in EBSS. In the present study, we found that the mRNA expression of ATG12 was significantly increased in HBVtransfected HepG2.2.15 cells when compared to HepG2 cells (p = 0.0039). In the case of ATG7, the mRNA expression of this gene was significantly down-regulated in HBV-transfected HepG2.2.15 cells (p < 0.0001). However, no significant difference was observed with ATG4B gene between HBVtransfected HepG2.2.15 cells and HepG2 cells (Figure 1) . Furthermore, we confirmed the results of mRNA level with Western blot analysis. We consistently found that ATG12 protein was upregulated in HBV-transfected HepG2.2.15, whereas ATG7 was down-regulated compared to HepG2 cells. As for ATG4B protein expression, there was no difference between these two cells (Figure 2) . The ATG12 protein expression was also upregulated in non-starved HepG2.2.15 cells compared to the HepG2 cells (Figure 3 ).
Decreased ATG12 affects HBV replication.
ATG12 is required for ubiquitin-like conjugation systems in the early steps of autophagosome formation. 8 We hypothesised that HBV induces the up-regulation of ATG12 to benefit its replication. To test this hypothesis, we knocked-down the ATG12 gene in HepG2.2.15 cells with ATG12 shRNA. Our results showed that the protein level of ATG12 in the cells treated with ATG12 shRNA was decreased when compared to the mock control ( Figure 4A) . To determine the effect of ATG12 on HBV replication, HBV DNA was quantified from shATG12-transfected cells compared to mock cells. Our findings showed that HBV DNA was diminished in shATG12-transfected HepG2.2.15 cells in comparison to the mock control (p < 0.05) ( Figure  4B) . Therefore, the impairment of ATG12 reduces HBV replication in HepG2.2.15 cells. In addition, we performed an apoptosis assay to confirm that the role of ATG12 in HBV replication in HepG2.2.15 cells was not due to cell death. In this study, we found an increase of apoptotic cells in shATG12- 
Silencing of ATG12 in HBV-transfected cells induces interferon (IFN) signalling
It has been reported that HCV infection enhances IFN signalling in autophagy-knockdown immortalised human hepatocytes (IHHs). 15 Thus, we determined whether or not the knockdown of the ATG12 gene after HBV infection affects the IFN signalling pathway. To verify this, the mRNA expression of IFN-α, IFN-β and two interferon-inducible genes (IFI27 and Mx1) was analysed. Our results show that IFN-α, IFN-β and IFI27 were significantly upregulated in shATG12 HepG2.2.15 cells when compared to mock treatment cells. However, no significant difference in the Mx1 gene was found in this study ( Figure 4C ). Therefore, these results suggest that inhibition of ATG12 enhances IFN signalling in HBV-transfected HepG2.2.15 cells.
Discussion
In this study, we analysed the role of autophagyrelated genes (ATG4B, ATG7, and ATG12) on HBV infection. We determined the expression profile of these autophagic genes in HBVtransfected HepG.2.15 cells and parental HepG2 cells and found that ATG12 was significantly up- regulated in HepG2.2.15 cells when compared with HepG2 cells, which was consistent with our protein expression results. ATG12 is an ubiquitin-like protein that is important in the expansion and completion of the early steps of autophagosome formation. 16 Our functional study of ATG12 in HepG2.2.15 cells transfected with shATG12 showed that viral DNA was decreased. Moreover, we demonstrated that IFN-α and IFN-β as well as IFI27 mRNA expressions were up-regulated in shATG12-transfected HepG2.2.15 cells. This is consistent with the study of Shrivastava et al., which demonstrated that even in different families of viruses, after silencing of some autophagy genes in HCV-infected IHHs, an increased expression of IFN-α, IFN-β, and IFI27 was found. 15 Moreover, a previous report showed that ATG12-ATG5 conjugate inhibits type I IFN production through the caspase recruitment domains (CARDs) by binding with the retinoic acidinducible gene I (RIG-I) and IFN-β promoter stimulator 1 (IPS-1) in mouse embryonic fibroblasts (MEFs). 17 Our result confirmed the role of ATG12 in IFN production, although we did not directly show the effect of ATG12-ATG5 conjugate.
Therefore, we suggest that ATG12 is required for HBV replication and impediment of the IFN signalling pathway. These findings raise the possibility of targeting the autophagic pathway for the treatment of HBV patients. Furthermore, our study showed that ATG7 was significantly down-regulated in HepG2.2.15 cells when compared with HepG2 cells under induction of autophagy. ATG7 is homologous to the E1 ubiquitin-activating enzyme, which is an essential enzyme in two ubiquitin-like protein conjugation systems. It is required for the conjugation of ATG12 to ATG5 and the activation of ATG8 to form autophagosomes. 18, 19 Several studies reported that autophagy was inhibited after siAtg7 transfection. 20, 21 A study by Tanida et al. showed that the level of HCV particles in the medium was decreased by the ATG7-knockdown. 11 For HBV, however, a study by Sir et al. found that knocking down ATG7 with siRNA led to the suppression of HBV DNA replication, which was similar to the PI3KC3 results. 3 In order to verify our findings, further study of the overexpression of ATG7 is needed to clarify its biological function in HBV infection.
In terms of ATG4B, our results demonstrated that ATG4B was not significantly different between HepG2.2.15 cells and HepG2 cells. ATG4B is a dominant protease enzyme that cleaves the ATG8/LC3 for the conjugation process of ATG8/LC3 and phosphatidylethanolamine. 22 A previous study showed that ATG4B is required for HCV replication. 10 Nevertheless, our negative findings suggest that ATG4B might not participate in HBV infection.
In conclusion, our study demonstrated the role of autophagy machinery in HBV replication. We found that ATG12-knockdown reduces HBV DNA level in HepG2.2.15 cells and induces the IFN signalling pathway. Thus, this ATG12 machinery of autophagy may aid HBV survival by reducing antiviral innate immunity. However, there might be other autophagy components or other mechanisms involved in HBV persistence; therefore, clarification of the interaction between autophagy and other pathways in hepatitis B disease warrants future study.
